XPONENTIAL FITNESS INC-A (XPOF)

US98422X1019 - Common Stock

15.26  +1.31 (+9.39%)

After market: 15.5 +0.24 (+1.57%)

Fundamental Rating

4

Overall XPOF gets a fundamental rating of 4 out of 10. We evaluated XPOF against 133 industry peers in the Hotels, Restaurants & Leisure industry. There are concerns on the financial health of XPOF while its profitability can be described as average. XPOF has a correct valuation and a medium growth rate.



4

1. Profitability

1.1 Basic Checks

In the past year XPOF was profitable.
In the past year XPOF had a positive cash flow from operations.
In the past 5 years XPOF reported 4 times negative net income.
XPOF had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

XPOF's Return On Assets of -5.23% is on the low side compared to the rest of the industry. XPOF is outperformed by 79.23% of its industry peers.
XPOF has a better Return On Invested Capital (13.83%) than 83.85% of its industry peers.
Industry RankSector Rank
ROA -5.23%
ROE N/A
ROIC 13.83%
ROA(3y)-4.27%
ROA(5y)-5.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a decent Operating Margin value of 18.76%, XPOF is doing good in the industry, outperforming 76.15% of the companies in the same industry.
XPOF has a Gross Margin of 75.01%. This is amongst the best in the industry. XPOF outperforms 91.54% of its industry peers.
In the last couple of years the Gross Margin of XPOF has grown nicely.
Industry RankSector Rank
OM 18.76%
PM (TTM) N/A
GM 75.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.14%
GM growth 5Y6.53%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so XPOF is still creating some value.
The number of shares outstanding for XPOF has been reduced compared to 1 year ago.
The debt/assets ratio for XPOF is higher compared to a year ago.

2.2 Solvency

XPOF has an Altman-Z score of 0.05. This is a bad value and indicates that XPOF is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of XPOF (0.05) is worse than 83.08% of its industry peers.
XPOF has a debt to FCF ratio of 278.36. This is a negative value and a sign of low solvency as XPOF would need 278.36 years to pay back of all of its debts.
With a Debt to FCF ratio value of 278.36, XPOF is not doing good in the industry: 65.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 278.36
Altman-Z 0.05
ROIC/WACC1.37
WACC10.07%

2.3 Liquidity

A Current Ratio of 1.02 indicates that XPOF should not have too much problems paying its short term obligations.
With a Current ratio value of 1.02, XPOF perfoms like the industry average, outperforming 56.92% of the companies in the same industry.
A Quick Ratio of 0.90 indicates that XPOF may have some problems paying its short term obligations.
With a Quick ratio value of 0.90, XPOF perfoms like the industry average, outperforming 55.38% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.9

6

3. Growth

3.1 Past

XPOF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 117.53%, which is quite impressive.
XPOF shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.00%.
The Revenue has been growing by 39.98% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)117.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.36%
Revenue 1Y (TTM)9%
Revenue growth 3Y44.05%
Revenue growth 5Y39.98%
Sales Q2Q%0.07%

3.2 Future

Based on estimates for the next years, XPOF will show a very strong growth in Earnings Per Share. The EPS will grow by 95.47% on average per year.
Based on estimates for the next years, XPOF will show a small growth in Revenue. The Revenue will grow by 7.75% on average per year.
EPS Next Y142.25%
EPS Next 2Y155.62%
EPS Next 3Y121.59%
EPS Next 5Y95.47%
Revenue Next Year2.51%
Revenue Next 2Y4.98%
Revenue Next 3Y6.62%
Revenue Next 5Y7.75%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 89.76 indicates a quite expensive valuation of XPOF.
Compared to the rest of the industry, the Price/Earnings ratio of XPOF indicates a slightly more expensive valuation: XPOF is more expensive than 63.85% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of XPOF to the average of the S&P500 Index (27.41), we can say XPOF is valued expensively.
With a Price/Forward Earnings ratio of 9.73, the valuation of XPOF can be described as very reasonable.
94.62% of the companies in the same industry are more expensive than XPOF, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.69, XPOF is valued rather cheaply.
Industry RankSector Rank
PE 89.76
Fwd PE 9.73

4.2 Price Multiples

XPOF's Enterprise Value to EBITDA ratio is in line with the industry average.
Based on the Price/Free Cash Flow ratio, XPOF is valued a bit more expensive than 64.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 584.97
EV/EBITDA 13.52

4.3 Compensation for Growth

XPOF's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as XPOF's earnings are expected to grow with 121.59% in the coming years.
PEG (NY)0.63
PEG (5Y)N/A
EPS Next 2Y155.62%
EPS Next 3Y121.59%

0

5. Dividend

5.1 Amount

No dividends for XPOF!.
Industry RankSector Rank
Dividend Yield N/A

XPONENTIAL FITNESS INC-A

NYSE:XPOF (1/3/2025, 8:11:37 PM)

After market: 15.5 +0.24 (+1.57%)

15.26

+1.31 (+9.39%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners77.34%
Inst Owner Change7.93%
Ins Owners4.06%
Ins Owner Change-1.93%
Market Cap737.06M
Analysts82.67
Price Target19.49 (27.72%)
Short Float %12.25%
Short Ratio6.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-20.96%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-113.82%
Min EPS beat(2)-114.66%
Max EPS beat(2)-112.98%
EPS beat(4)0
Avg EPS beat(4)-75.83%
Min EPS beat(4)-114.66%
Max EPS beat(4)-27.04%
EPS beat(8)0
Avg EPS beat(8)-207.46%
EPS beat(12)0
Avg EPS beat(12)-176.47%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.54%
Min Revenue beat(2)-10.3%
Max Revenue beat(2)3.21%
Revenue beat(4)2
Avg Revenue beat(4)-0.04%
Min Revenue beat(4)-10.3%
Max Revenue beat(4)7.98%
Revenue beat(8)6
Avg Revenue beat(8)2.69%
Revenue beat(12)10
Avg Revenue beat(12)6.29%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.12%
EPS NY rev (1m)18.75%
EPS NY rev (3m)-27.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-15.81%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 89.76
Fwd PE 9.73
P/S 2.26
P/FCF 584.97
P/OCF 90.47
P/B N/A
P/tB N/A
EV/EBITDA 13.52
EPS(TTM)0.17
EY1.11%
EPS(NY)1.57
Fwd EY10.28%
FCF(TTM)0.03
FCFY0.17%
OCF(TTM)0.17
OCFY1.11%
SpS6.76
BVpS-0.81
TBVpS-6.62
PEG (NY)0.63
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.23%
ROE N/A
ROCE 16.21%
ROIC 13.83%
ROICexc 14.8%
ROICexgc 72.15%
OM 18.76%
PM (TTM) N/A
GM 75.01%
FCFM 0.39%
ROA(3y)-4.27%
ROA(5y)-5.68%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.14%
GM growth 5Y6.53%
F-Score3
Asset Turnover0.69
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 278.36
Debt/EBITDA 4.35
Cap/Depr 39.67%
Cap/Sales 2.11%
Interest Coverage 1.49
Cash Conversion 10.36%
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.9
Altman-Z 0.05
F-Score3
WACC10.07%
ROIC/WACC1.37
Cap/Depr(3y)71.01%
Cap/Depr(5y)78.33%
Cap/Sales(3y)4.32%
Cap/Sales(5y)4.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)117.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-136.36%
EPS Next Y142.25%
EPS Next 2Y155.62%
EPS Next 3Y121.59%
EPS Next 5Y95.47%
Revenue 1Y (TTM)9%
Revenue growth 3Y44.05%
Revenue growth 5Y39.98%
Sales Q2Q%0.07%
Revenue Next Year2.51%
Revenue Next 2Y4.98%
Revenue Next 3Y6.62%
Revenue Next 5Y7.75%
EBIT growth 1Y42.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.17%
EBIT Next 3Y41.47%
EBIT Next 5Y34.38%
FCF growth 1Y-96.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-83.02%
OCF growth 3YN/A
OCF growth 5Y111.35%